Press Releases

Arch Therapeutics to Present at The LD 500 Virtual Conference on Tuesday, September 1 at 1 PM ET
Arch Therapeutics Novel Self-Assembling Agent, AC5-GTM, for Use in Endoscopic Procedures was Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting
Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Virtual 2020 Annual Meeting Starting August 11, 2020
Arch Therapeutics, Inc. to Present at the Virtual Investor Fireside Chat Series
Arch Raises $1.4 Million with Convertible Note Issuance and Warrant Reprice
Arch Therapeutics to Provide Corporate Update at the Virtual Summer Summit
Arch Therapeutics Receives CE Mark Approval for AC5™ Topical Hemostat in Europe
Arch Therapeutics Receives Marketing Clearance from the US FDA Related to the AC5® Topical Gel Supply Chain
Arch Therapeutics, Inc. to Present at the New York City based Investor Summit on March 25th-26th
Arch Therapeutics Novel Self-Assembling Agent for Use in Endoscopic Procedures to be Presented at the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) 2020 Annual Meeting on April 2, 2020
RSS
Show All